Active ingredientIxazomibCat. No. P-I110-001CAS 1072833-77-2Family · Pharmaceutical analytical standards
Ixazomib
A proteasome inhibitor, blocking the system that disposes of proteins cells no longer need. Approved in the United States in 2015 and in Europe in 2016 for multiple myeloma, it is taken by mouth, unlike bortezomib, which must be injected. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?It contains a boron atom: it is a boronic acid built on the skeleton of the amino acid leucine, and it is taken as a citrate ester that quickly releases the active form in the body.
Go to the active ingredient →Active ingredientIxazomibCat. No. P-I110-001CAS 1072833-77-2
Active ingredientIxazomib CitrateCat. No. P-I110-002CAS 1239908-20-3
NitrosamineN1-Nitroso Ixazomib CitrateCat. No. P-I110-004
NitrosamineN2-Nitroso Ixazomib CitrateCat. No. P-I110-005
Impurity(S)-Ixazomib CitrateCat. No. P-I110-006
Impurity(S)-Ixazomib TrimerCat. No. P-I110-007
ImpurityDeboronated IxazomibCat. No. P-I110-008CAS 2872629-73-5
ImpurityIxazomib Impurity 1Cat. No. P-I110-009CAS 1201903-02-7
ImpurityIxazomib Impurity 2Cat. No. P-I110-010
ImpurityIxazomib Impurity 3Cat. No. P-I110-011
ImpurityIxazomib Impurity 4Cat. No. P-I110-012
ImpurityIxazomib Impurity 5Cat. No. P-I110-013
ImpurityIxazomib Impurity 6Cat. No. P-I110-015
ImpurityIxazomib Impurity 7Cat. No. P-I110-016
ImpurityIxazomib Impurity 8Cat. No. P-I110-017
ImpurityIxazomib Impurity 9Cat. No. P-I110-018
ImpurityIxazomib Impurity 11Cat. No. P-I110-020
ImpurityIxazomib Impurity 12Cat. No. P-I110-021
ImpurityIxazomib Impurity 13Cat. No. P-I110-022
ImpurityIxazomib Impurity 14Cat. No. P-I110-023
ImpurityIxazomib Impurity 15Cat. No. P-I110-024
ImpurityIxazomib Impurity 16Cat. No. P-I110-025
ImpurityIxazomib Impurity 17Cat. No. P-I110-026
ImpurityIxazomib Impurity 18Cat. No. P-I110-027
ImpurityIxazomib Impurity 19Cat. No. P-I110-028
ImpurityIxazomib Impurity 20Cat. No. P-I110-029
ImpurityIxazomib TrimerCat. No. P-I110-030CAS 1201903-03-8
ImpurityN-(2,5-Dichlorobenzoyl)glycineCat. No. P-I110-031CAS 667403-46-5
ImpurityIxazomib Impurity 21Cat. No. P-I110-032CAS 2920604-29-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.